Skip to content

Clinical effect of acupuncture treatment in obese people complicated with hyperlipidaemia: a randomised controlled study

Clinical effect of acupuncture treatment in obese people complicated with hyperlipidaemia: a randomised controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003387
Enrollment
Unknown
Registered
2020-06-10
Start date
2020-07-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity complicated with hyperlipidaemia

Interventions

Sponsors

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Participants who meet the diagnostic criteria of obesity, that is BMI between 28kg/m2 and 35 kg/m2; 2. Participants who meet the diagnostic criteria of hyperlipidaemia, including hypercholesterolemia, hypertriglyceridemia, combined hyperlipidaemia and low HDL cholesterolemia and meeting any of the following dyslipidemias: 5.2 mmol/L<= TC < 6.2 mmol/L; 1.7 mmol/L<= TG <= 2.3 mmol/L; 3.4 mmol/L <= LDL-C < 4.1 mmol/L; 4.1 mmol/L <= Non-HDL-C < 4.9mmol/L; HDL-C < 1.0 mmol/L; 3. Participants aged between 18 and 50 years; 4. Participants who volunteer to the study and sign up for the informed consent.

Exclusion criteria

Exclusion criteria: 1. Secondary obesity; 2. Women under lactation or pregnancy; 3. Participants who suffered arteriosclerotic cardiovascular diseases (ASCVD), or complicated with high risk factors like hypertension, diabetes mellitus, or who are judged to be at middle risk or high risk degree of ASCVD, or need to take lipid lowering drugs by the judgement of physicians; 4. Participants who complicated with severe primary diseases of important organs such as heart, liver and kidney; 5. Participants who complicated with severe diseases such as hematological system disorders, infectious diseases, malignant tumors and so on; 6. Participants who have taken weight-loss drugs within 3 months or have weight loss more than 5% within 3 months before enrollment; 7. Participants who have taken lipid-lowering drugs within 3 months before enrollment; 8. Participants who cannot cooperate with treatment of the study.

Design outcomes

Primary

MeasureTime frame
Total Cholesterol;Triglyceride;Body Mass Index;

Secondary

MeasureTime frame
HDL-C;Non-HDL-C;Body Mass Index;body weight;waist circumference;LDL-C;waist circumference;body weight;

Countries

China

Contacts

Public ContactChangcai Xie

Guangdong Provincial Hospital of Traditional Chinese Medicine

hxie114@163.com+86 13650997551

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026